Multifunctional degradable tissue bonding patch as well as preparation method and application thereof

By crosslinking modified chitin membranes with polysaccharide polymers containing dopamine and aldehyde groups, and combining thermosensitive modified chitin with antibacterial quaternized groups, a biodegradable tissue adhesive patch was prepared. This solved the problems of adhesion strength and biocompatibility of existing bioadhesives, and achieved efficient and controllable tissue adhesion and antibacterial therapeutic effects.

CN118892571APending Publication Date: 2024-11-05WUHAN UNIV

Patent Information

Application Number
CN202411017898.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-29
Publication Date
2024-11-05

Smart Images

  • Figure CN118892571A_ABST
    Figure CN118892571A_ABST
Patent Text Reader

Abstract

The invention discloses a multifunctional degradable tissue bonding patch and a preparation method and application thereof.The preparation method comprises the steps that firstly, an alkaline urea low-temperature chitin aqueous solution is utilized, a side chain modified etherification reagent is added for homogeneous reaction, modified chitin with temperature or pH sensitivity is prepared, then the aqueous solution is solidified, regenerated and purified, and a temperature-sensitive modified chitin film is prepared. Then, a toughening agent and dopamine are introduced to modify degradable adhesive macromolecules, and the degradable composite tissue adhesive patch with high adhesion strength and photo-thermal antibacterial multiple effects is prepared. The method has the advantages of simple preparation process, no use of any micromolecular chemical cross-linking agent, good biocompatibility and biodegradability, good tissue adhesiveness in a humid environment, good plugging, leak repairing and arterial blood stopping effects, and can be used for tissue adhesion plugging and leak repairing, wound wireless suture and arterial hemostasis plugging; and the material can promote wound tissue healing, and has good application in the fields of biological medicines, medical instruments, tissue engineering materials and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of biomedical materials and preparation thereof, and specifically relates to a multifunctional degradable tissue adhesive patch material and a preparation method and application thereof. Background Art

[0002] In military warfare and ordinary accidents, tissue trauma and related acute bleeding are the main causes of death. The current treatment of hemorrhagic injuries usually stops bleeding first and then sutures. The typical disadvantages of suturing are long time, complex operation, further tissue damage, infection, and damage caused by the later suture removal process, and are accompanied by significant post-healing scars. Since the gastrointestinal organs need to be closed, suturing is often accompanied by a high anastomotic leakage rate (i.e., up to 20% in high-risk patients), leading to serious complications, including infection, sepsis, and even death. Therefore, surgical hemostasis, repair of gastrointestinal defects to provide mechanical sealing and good healing remain an ongoing challenge, highlighting the importance of developing new materials, new treatment methods, and solutions.

[0003] Tissue adhesives with tissue integration can achieve wound adhesion through the chemical and physical effects of materials, effectively reduce clinical surgical operation time, effectively seal air and body fluid leakage, close wounds more quickly, and do not require cleaning to minimize treatment invasiveness, reduce additional trauma and secondary blood loss caused by secondary treatment, especially when facing some irregular wound surfaces, they are more applicable and can accelerate wound recovery. They have attracted attention in the field of wound closure due to their significant advantages. At present, a variety of biological tissue adhesive materials have been developed, mainly including natural tissue adhesives and synthetic tissue adhesives. Common natural tissue adhesives include adhesives based on fibrin, gelatin, collagen, polysaccharides, polypeptides, etc. These adhesives have the advantages of good biocompatibility and high safety; common synthetic adhesives include cyanoacrylate adhesives and polyethylene glycol adhesives, which have the advantages of high bonding strength. However, these tissue adhesives still have various limitations in clinical treatment. For example, fibrin glue has excellent tissue compatibility, but weak adhesion strength, making it difficult to achieve tissue wound anastomosis; while tissue glue represented by cyanoacrylate can show stronger adhesion strength, but has poor tissue compatibility and biodegradability, and can cause severe host reactions. Existing tissue adhesives and sealants are usually used in the form of viscous liquids, which usually need to diffuse and penetrate into tissues or blood vessels, and may even cause thrombosis in severe cases. In addition, most of these biological tissue adhesives are designed for double-sided adhesion. Due to their indiscriminate adhesion to surrounding tissues / organs and adhesion-induced inflammatory reactions, they inevitably lead to postoperative tissue adhesion and scar tissue formation, requiring re-admission and re-surgery to avoid chronic pelvic pain, intestinal obstruction and infertility. In addition, in many application scenarios, the tissues or tissue wounds that need to be bonded will be in a moist environment or immersed in liquid. The moist environment will affect the bonding properties of the adhesive, and the adhesive is diluted or washed away by the liquid on the biological tissue, resulting in reduced bonding properties or the risk of displacement of the adhesive. Therefore, it is very necessary to develop a new type of biocompatible tissue adhesive patch with easy use, fast adhesion, high adhesion strength and controllable adhesion interface. The ideal tissue adhesive should have good tissue integration, biocompatibility, and full biodegradability, which can avoid the impact of secondary surgical treatment on patients. In addition, if the tissue adhesive itself has certain antibacterial properties, it can effectively reduce the abuse of antibiotics and the generation of drug-resistant bacteria. Therefore, the research and development of tissue adhesives is of great significance. Summary of the invention

[0004] In order to address the deficiencies of the prior art, the purpose of the present invention is to provide a multifunctional degradable tissue adhesive patch material and its preparation method and application, which has photothermal effect, antibacterial properties and good tissue adhesive properties, can be used for moist tissue adhesion, leak repair and hemostasis, can be used for irregular wound shapes, effectively promote wound healing, and has wide application in the field of biomedical materials.

[0005] In order to achieve the above object, the technical solution of the present invention is: A method for preparing a degradable tissue adhesive patch comprises the following steps: S100, preparing a modified chitosan film; S200, soaking the modified chitosan film in a toughening agent solution for toughening and modification, and obtaining a toughened and modified chitosan film after drying; S300, immersing the toughened modified chitosan film in a mixed solution containing a toughening agent and a degradable adhesive polymer to perform an in-situ crosslinking reaction, wherein the degradable adhesive polymer is a polysaccharide polymer containing both a dopamine group and an aldehyde group; S400, then drying the toughened modified chitosan film in an air environment to obtain a degradable tissue adhesive patch.

[0006] The present invention adopts a modified chitin membrane as a matrix material, which has good biocompatibility and degradability. It does not need to be removed after use and can be self-biodegradable. When used as a tissue adhesive material, it can avoid additional trauma and secondary blood loss caused by secondary treatment of patients; the present invention uses a toughening agent to toughen the modified chitin membrane, which can improve the toughness of the modified chitin membrane such as elongation at break, and effectively prevent the tissue from breaking due to insufficient toughness during adhesion; the present invention uses a polysaccharide polymer containing dopamine groups and aldehyde groups to perform physical entanglement and in-situ partial chemical cross-linking ammonia (amine) aldehyde Schiff base reaction, and in-situ cross-linking to improve the strength of the modified chitin membrane. At the same time, dopamine groups and aldehyde groups are introduced to obtain adhesion to tissues. After toughening and strengthening modification, a higher strength (50 MPa or more) and good elongation at break, plus good tissue adhesion ability (adhesion strength is higher than 40kPa), the degradation time reaches 8 days or more, so that the film prepared by the present invention has very good adhesion, and can be used as a tissue patch for blocking wounds, tissue perforations, trauma and other application scenarios that require sutures in the prior art, creating a suture-free trauma treatment method, especially suitable for outdoor emergency and other occasions. After preparing the obtained degradable tissue adhesive patch, the present invention also found that it has antibacterial, hemostatic and photothermal treatment effects, so it is a very ideal trauma treatment material.

[0007] It should be noted that the modified chitosan film is a film obtained by using modified chitosan using film-forming means. The modified chitosan mainly refers to the introduction of new groups into the side chains of chitosan, and the degree of modification is 0.07-0.20 (on average, 7-20 units of 100 chitosan sugar units have new groups introduced into the side chains), and the degree of acetylation is maintained at 0.72-0.94, so as to obtain better film performance and in vivo degradability. The groups introduced by modification include but are not limited to hydroxypropyl, hydroxyethyl, carboxymethyl, hydroxybutyl or quaternary ammonium groups, and the corresponding modified chitosan includes but is not limited to hydroxypropyl chitosan, hydroxyethyl chitosan, carboxymethyl chitosan, hydroxybutyl chitosan or quaternary ammonium chitosan.

[0008] Furthermore, in step S200, the toughening agent is a low molecular weight polyol, which may be glycerol, polyethylene glycol, etc., wherein the molecular weight of the polyethylene glycol may be in the range of 200-20000.

[0009] Furthermore, in step S200, the mass concentration of the polyol solution is 4-9 wt%, and no toughening agent is added or too little toughening agent is added. The resulting modified chitosan film has poor toughness and is easily brittle. The toughened modified chitosan film with the addition of a toughening agent has significantly improved strength and toughness. However, the tensile fracture strength of the toughened modified chitosan film obtained when immersed in an aqueous solution of a toughening agent with a higher concentration is significantly reduced. Therefore, when the mass concentration of the polyol solution is 4-9 wt%, the strength and toughness of the modified chitosan film can be better improved, so that it meets the requirements as a tissue bonding substrate.

[0010] Furthermore, in step S200, the modified chitosan film is immersed in the toughening agent solution for 4-48 hours, preferably 8-24 hours; there is no special requirement for the immersion time, generally, the modified chitosan film can reach swelling equilibrium in the toughening agent solution.

[0011] Furthermore, in step S200, the drying method after soaking is freeze drying, vacuum drying, natural drying in air atmosphere, forced ventilation drying or heating drying at no more than 60°C.

[0012] Furthermore, in step S300, the degradable adhesive polymer is dopamine-hydrogenated hyaluronic acid or dopamine-hydrogenated carboxymethyl chitosan.

[0013] The preparation of dopamine-formylated hyaluronic acid is carried out by oxidizing hyaluronic acid to obtain formylated hyaluronic acid, and then the formylated hyaluronic acid and dopamine hydrochloride are reacted by Schiff base to obtain dopamine-grafted formylated hyaluronic acid.

[0014] The preparation of dopamine-formaldehyde carboxymethyl chitin is that the formaldehyde carboxymethyl chitin is obtained by oxidizing carboxymethyl chitin, and then the formaldehyde carboxymethyl chitin is reacted with dopamine hydrochloride through Schiff base to obtain dopamine-grafted formaldehyde carboxymethyl chitin.

[0015] Furthermore, in step S300, the time of the in-situ cross-linking reaction is 4-72 hours, and more preferably 12-48 hours.

[0016] Furthermore, in step S300, the hydroformylation rate of the polysaccharide polymer is 0.20-0.70, and more preferably 0.30-0.60.

[0017] Furthermore, in step S300, the molar substitution degree of dopamine is 0.15-0.55, and more preferably 0.2-0.45.

[0018] The hydroformylation rate of polysaccharide polymers and the molar substitution degree of dopamine directly affect the adhesion ability and photothermal therapy ability. Only within the above range can a better adhesion strength be obtained.

[0019] Furthermore, in step S300, the weight average molecular weight of hyaluronic acid is in the range of 2×10 4 ~8×10 6 , preferably 8×10 4 ~1.0×10 6 Hyaluronic acid with an appropriate molecular weight can obtain an appropriate degradation time. If the degradation time is too short, the tissue wound has not healed yet, and the adhesive patch loses its due strength and toughness and cannot play the adhesive role.

[0020] Furthermore, in step S300, the concentration of the toughening agent in the mixed solution is matched with the concentration of the toughening agent solution in the toughening modification. The matching means that the concentration of the toughening agent in the mixed solution is roughly the same as the concentration of the toughening agent solution in the toughening modification. This is to maintain the toughening modification effect in step S200 and prevent the toughness of the modified chitin membrane from changing due to inconsistent concentrations, thereby failing to meet the design requirements.

[0021] Furthermore, in step S300, the concentration of the degradable adhesive polymer in the mixed solution is 2-10 wt %; the concentration of the degradable adhesive polymer directly affects the strength of the degradable tissue adhesive patch after cross-linking, and better strength can be obtained within this range.

[0022] On the other hand, the present invention also provides a method for preparing the modified chitosan film in step S100, which is specifically as follows: S110, dissolving the modified chitosan in an alkaline solution to prepare a modified chitosan solution; S120, spreading the modified chitosan solution on a flat plate, adjusting the thickness to a desired value, and then immersing the flat plate in a coagulation bath to regenerate a film; S130, separating the obtained membrane from the plate, washing and purifying it to obtain a modified chitin membrane.

[0023] Furthermore, in step S110, the modified chitosan is a thermosensitive modified chitosan, which means that it can be dissolved in an alkaline aqueous solution at low temperature, and phase transition will occur when the temperature is increased. The aqueous solution is regenerated and purified in a coagulation bath to prepare a regenerated modified chitosan substrate film material. The regenerated film material is insoluble under physiological conditions and has good wet strength. The acetylation degree of the thermosensitive modified chitosan is 0.72-0.94 (it has some amino reactive groups and good in vivo degradability, and is thermosensitive); its weight average molecular weight is 5×10 3 ~5×10 6 .

[0024] Furthermore, in step S110, the modified chitosan is prepared by using the disclosed technologies of patents CN116948056A, CN116535540B, CN116102769A, CN111378200A, etc.

[0025] Thermosensitive modified chitosan is used because it can be well dissolved in alkaline solution and obtain better film-forming performance. Generally speaking, natural chitosan is difficult to dissolve in water and difficult to form an effective film. Therefore, modified chitosan is needed. Thermosensitive modified chitosan is one of the modified chitosans that have been experimentally verified to have better film-forming performance.

[0026] When using temperature-sensitive modified chitosan, it should be dissolved in alkaline water at low temperature, which generally refers to 0-20°C. For reversible temperature-sensitive modified chitosan, it can be dissolved in pure water, and the dissolution temperature should be lower than its temperature-sensitive transition temperature.

[0027] Furthermore, in step S110, the temperature-sensitive modified chitosan is a temperature-sensitive antibacterial quaternized chitosan, wherein the temperature-sensitive quaternized chitosan used has an acetylation degree of 0.88-0.94, a quaternization substitution degree of 0.07-0.17, and a weight average molecular weight of 5×10 4 ~5×10 6 ; Because quaternized chitosan introduces positively charged quaternized groups with endogenous antibacterial properties, the tissue adhesive patch is endowed with good biodegradability and antibacterial properties. It can fix damaged tissues while avoiding wound infection, reducing the abuse of antibiotics and promoting the repair and regeneration of damaged parts.

[0028] Furthermore, in step S110, the temperature-sensitive modified chitosan may also be preferably any one or a combination of temperature-sensitive hydroxypropyl chitosan, temperature-sensitive hydroxyethyl chitosan, temperature-sensitive carboxymethyl chitosan or temperature-sensitive hydroxybutyl chitosan.

[0029] Furthermore, in step S110, the alkali solution is generally a strong base, such as the most commonly used NaOH solution for modified chitosan; since the temperature-sensitive modified chitosan has good solubility in low-temperature alkali solution, the concentration of the alkali solution does not need to be too high; the temperature-sensitive modified chitosan is dissolved in 0.2-2.0 M NaOH solution to form a 3-8 wt% solution.

[0030] More preferably, the temperature-sensitive modified chitosan is dissolved in a 0.5-1.5 M NaOH solution to prepare a 4-6 wt % polymer aqueous solution.

[0031] Further preferably, after preparing the modified chitosan solution, a low-temperature centrifugal degassing treatment is performed to improve the subsequent film-forming quality.

[0032] Furthermore, in step S120, the flat plate may be a common light plate such as a glass plate or a ceramic plate, and the thickness of the modified chitosan solution spread on the flat plate is generally 0.5-1.0 mm.

[0033] Furthermore, in step S120, the coagulation bath is any one of a methanol aqueous solution, an ethanol aqueous solution or an acetone aqueous solution.

[0034] It should be noted that the temperature of the coagulation bath varies according to different modified chitosans, and generally there is no universal range; for example, when the modified chitosan is a thermosensitive quaternary ammonium chitosan with a substitution degree of 0.07-0.17 and an acetylation degree of 0.88-0.94, the temperature of the coagulation bath is 10°C-30°C, and the immersion time is 0.5-3 days. When the modified chitosan is a thermosensitive carboxymethyl chitosan with a substitution degree of 0.07-0.20, the temperature of the coagulation bath is -30-30°C; the regeneration time of the coagulation bath is based on the end of the regeneration, the longer the better, of course, the time process will cause time waste, generally 0.5-3 days.

[0035] Furthermore, in step S120, the volume concentration of the methanol aqueous solution is 50%-100%; the volume concentration of the ethanol aqueous solution is 50%-100%; and the volume concentration of the acetone aqueous solution is 50%-100%.

[0036] Furthermore, in step S130, the regeneration membrane separation method is to tear it off completely, and the washing and purification is to immerse it in deionized water to remove the residual coagulation bath and other small molecular residues; the washing and purification time is 1-7 days.

[0037] In another aspect, the present invention provides a degradable tissue adhesive patch prepared by any one of the preparation methods described above.

[0038] On the other hand, the present invention also protects the use of the degradable tissue adhesive patch in the preparation of hemostatic products, products promoting wound tissue healing, tissue adhesive products, wound suturing or photothermal antibacterial repair products. It can be used for arterial hemostatic materials, arterial hemostatic patches and deep and narrow penetrating wounds to block and stop bleeding, promote wound tissue healing, and can also be used for tissue adhesive blocking and leak repair, wireless wound suturing and photothermal antibacterial repair materials.

[0039] Preferably, when the multifunctional degradable tissue patch is used, the surface of the tissue to be adhered or blocked is treated with an aqueous solution of an oxidant to promote in situ cross-linking between the tissue patch and the tissue to generate a stronger polymer network gel.

[0040] Preferably, when the multifunctional degradable tissue patch is used, the surface of the tissue to be adhered or blocked is treated with an aqueous oxidant solution, wherein the oxidant comprises a low concentration sodium periodate aqueous solution, and the mass percentage concentration of the sodium periodate aqueous solution is preferably 2-10%.

[0041] The present invention combines a thermosensitive modified chitin substrate film and a degradable adhesive polymer, and forms a multifunctional degradable tissue adhesive solid patch through physical entanglement between polymer chains and in-situ partial chemical cross-linking ammonia (amine) aldehyde Schiff base reaction. The acetylation degree of the thermosensitive modified chitin used is 0.72-0.94 (it has partial amino reactive groups and good in vivo degradability, and is thermosensitive); its weight average molecular weight is 5×10 3 ~5×10 6 The degradable adhesive polymer is a degradable polymer containing both dopamine groups and aldehyde groups. The temperature-sensitive modified chitosan refers to chitosan that can be dissolved in an alkaline aqueous solution at low temperatures, and undergoes phase transition when heated. The aqueous solution is regenerated and purified in a coagulation bath to prepare a regenerated modified chitosan substrate film material. The regenerated film material is insoluble under physiological conditions and has good wet strength.

[0042] The single-sided pig skin adhesion strength of the degradable tissue adhesive patch reaches more than 40 kPa, and the degradation time reaches 8 days or more. The hydroformylation rate of the polysaccharide polymer is in the range of 0.20-0.70, preferably in the range of 0.30-0.60, the molar substitution degree of dopamine is in the range of 0.15-0.55, preferably in the range of 0.2-0.45, and the weight average molecular weight of hyaluronic acid is in the range of 2×10 4 ~8×10 6 , preferably 8×10 4 ~1.0×10 6 .

[0043] Compared with the prior art, this technology has the following beneficial effects: (1) The present invention combines a thermosensitive modified chitosan substrate film with a degradable adhesive polymer, utilizes the physical entanglement between polymer chains and the in-situ partial chemical cross-linking ammonia (amine) aldehyde Schiff base reaction, and prepares a multi-functional degradable tissue adhesive solid patch. The present invention utilizes the characteristic of thermosensitive modified chitosan that it dissolves in an aqueous solution at low temperature, and regenerates the modified chitosan substrate film material through its aqueous solution in a coagulation bath. The regenerated film material is insoluble under physiological conditions and has good matrix wet strength. The preparation process is simple and is an environmentally friendly green process. No small molecule chemical cross-linking agent is used. The material is degradable and absorbable in the body and has good biocompatibility and biodegradability. It has good tissue adhesion and high tissue adhesion strength in a humid environment and good effect of sealing and stopping arterial bleeding.

[0044] (2) The degradable adhesive polymer used in the present invention is a degradable polymer containing both dopamine groups and aldehyde groups. Both types of groups have a certain affinity and adhesion to tissues, and can improve the wet adhesion strength to tissues. Since dopamine has good photothermal properties, it gives the tissue adhesive patch of the present invention a good photothermal antibacterial repair effect.

[0045] (3) When using degradable thermosensitive antibacterial quaternized chitosan, the quaternized chitosan introduces positively charged quaternized groups with endogenous antibacterial properties, which endows the tissue adhesive patch with good biodegradability and antibacterial properties. It can fix the damaged tissue while avoiding wound infection, reducing the abuse of antibiotics and promoting the repair and regeneration of damaged parts.

[0046] In addition, by applying a low-concentration sodium periodate oxidant aqueous solution to the tissue interface to be adhered, the choice of adhesion to different interfaces can be achieved, and the patch of the present invention can be adhered to one side or both sides. Only the tissue surface moistened with the oxidant sodium periodate aqueous solution can be adhered by the QCHFP tissue patch, while the tissue surface not moistened with the sodium periodate solution cannot be adhered by the QCHFP tissue patch, so no unnecessary adhesion will be generated to other tissues, and controllable adhesion to the required tissues can be achieved, avoiding indiscriminate adhesion to surrounding tissues / organs (postoperative tissue adhesion and scar tissue formation) and adhesion-induced inflammatory response. BRIEF DESCRIPTION OF THE DRAWINGS

[0047] Figure 1 The figure is an overall flow chart of preparing a degradable tissue adhesive patch in an embodiment of the present invention.

[0048] Figure 2 The mechanical properties of the QCH2 films with different glycerol immersion concentrations in the embodiments of the present invention are shown in FIG. Figure 2 a in the figure is the mechanical properties of the QCH2 film obtained by air drying. Figure 2 (b) shows the mechanical properties of the QCH2 film obtained by freeze drying.

[0049] Figure 3 This is the tensile stress-strain curve of the composite tissue adhesive patch QCHFP in Example 4 (in the figure, Q2F represents the QCH2 film not soaked in DAHA, QCHFP-2 (i.e., Q2DF-2) represents the composite tissue adhesive patch of the QCH2 film prepared by soaking in 2% DAHA, QCHFP-4 (Q2DF-4) represents the composite tissue adhesive patch of the QCH2 film prepared by soaking in 4% DAHA, QCHFP-6 (Q2DF-6) represents the composite tissue adhesive patch of the QCH2 film prepared by soaking in 6% DAHA, and QCHFP-10 (Q2DF-10) represents the composite tissue adhesive patch of the QCH2 film prepared by soaking in 10% DAHA).

[0050] Figure 4 The bonding properties of the composite tissue adhesive patch QCHFP (Q2DF) in Example 5: (a) Schematic diagram of the bonding mechanism; (b) The composite tissue adhesive patch can still adhere to pig skin after repeated stretching, twisting and bending or soaking in water for 10 days; (c) The tissue patch can still adhere to heart, liver, kidney and stomach tissues after being soaked in air and underwater for 10 days. Figure 5 The adhesion properties of the composite tissue adhesive patch QCHFP in Example 5: (a) schematic diagram of double-sided adhesion, and photos of adhesion in air and adhesion in water; (b) schematic diagram of single-sided adhesion, and photos of adhesion in air and adhesion in water; lap shear force curves (c, e) and adhesion strengths at different adhesion times (d, f); all statistical data are mean ± SD (n = 4).

[0051] Figure 6 Evaluation of the photothermal effect of the composite tissue adhesive patch in Example 6 (808 nm irradiation for 10 minutes): (a) Heating curves of QCHFP prepared by immersing in different concentrations (0, 2, 4, 5, 6 and 10%) of DAHA (laser power 2 W cm -2 ); (b) Heating curves of QCHFP-10 at different laser powers; (c) Temperature variation of QCHFP-10 patch during four cycles of laser on-off cycling (laser power 2 W cm -2 ); (d) Heating curves of QCHFP-10 patch at different laser powers after adhesion to pig skin.

[0052] Figure 7In Example 7, a schematic diagram of evaluating the photothermal antibacterial performance of the QCHFP tissue patch membrane using Staphylococcus aureus (CMCC 26003) and Escherichia coli (ATCC 25922) by the agar plate counting method is shown, wherein: Figure 7 (a) and (b) are photos and statistical graphs of the colonies of Escherichia coli (E. coli) when co-cultured with the composite tissue adhesive patch QCHFP (Q2DF) or the control without light or after 808 nm near-infrared light for 5 minutes; Figure 7 (c) and (d) show the colony status and statistical graphs of Staphylococcus aureus (S. aureus) when co-cultured with the composite tissue adhesive patch QCHFP (Q2DF) or the control without light or after 808 nm near-infrared light for 5 minutes. All statistical data are mean ± SD, n = 3. , .

[0053] Figure 8 Tissue sealing performance of the composite tissue adhesive patch QCHFP (Q2DF) in Example 8: Figure 8 (a), (b), and (c) are schematic diagrams of the bursting pressure test device for the rat uterine injury model in which blue dye was injected into the uterus, the untreated control group with incision leakage, the QCHFP (Q2DF) patch group with incision leakage, and the pig skin adhered; Figure 8 Middle (d) is the burst pressure of QCHFP patch and commercial control fibrin adhesive and tissue glue (vetbond) adhered to pig skin in air for 48 hours; Figure 8 Middle (e) is the burst pressure of QCHFP patch and commercial control fibrin adhesive and tissue glue (vetbond) adhered to pig skin after immersion in water for 48 hours; Figure 8 Middle (f) is the anti-leakage ability of QCHFP (Q2DF) patch, commercial control fibrin adhesive and control normal tissue in phosphate buffered saline (PBS 7.4); Figure 8 Middle (g) is the anti-leakage ability of QCHFP (Q2DF) patch, commercial control fibrin adhesive and control normal tissue in simulated intestinal fluid (SIF); Figure 8 Middle (h) is the anti-leakage ability of QCHFP (Q2DF) patch, commercial control fibrin adhesive and control normal tissue in simulated gastric fluid (SGF); The data were processed using t-test. , ,and .

[0054] Fig. 9 In Example 9, the photothermal repair of skin wounds, (a) is a schematic diagram of the photothermal repair of bacterially infected wound skin in rats; (b) is the change in wound area; (c) is a photograph of the wound with different patches (dressings) at different times without or with infrared light. The data were processed using the t-test. , , , n=5. Fig.10 Wireless suture repair of mouse skin with QCHFP patch in Example 10: (a) Schematic diagram of skin suture repair of incision; (b) Change of wound area; (c) Photos of incision at different times; (d) H&E and Masson staining pictures of tissue at the incision 15 days later (incision marked by yellow dotted line). Data were processed using t-test (Student's t-test), , , and .

[0055] Fig.11 The rat hemostasis model in Example 11: (a) is a schematic diagram of the normal rat liver defect hemostasis model, (b) is a photograph of hemostasis using different hemostatic materials in the normal rat liver defect hemostasis model, (c) is the amount of blood loss in the normal rat liver defect hemostasis model, and (d) is the amount of blood loss in the normal rat liver defect hemostasis model; (e) is a schematic diagram of the heparinized rat liver defect hemostasis model, (f) is a photograph of hemostasis using different hemostatic materials in the heparinized rat liver defect hemostasis model, (g) is the amount of blood loss in the heparinized rat liver defect hemostasis model, and (h) is the hemostasis time in the heparinized rat liver defect hemostasis model; (i) is a schematic diagram of the rat femoral artery hemostasis model, (j) is a photograph of hemostasis using different hemostatic materials in the rat femoral artery hemostasis model, (k) is the amount of blood loss in the rat femoral artery hemostasis model, and (l) is the hemostasis time in the rat femoral artery hemostasis model; the data were processed using the t-test. , , and , n = 4.

[0056] Fig.12 The QCHFP (Q2DF) patch seamless repair model of gastric perforation in rats in Example 12: (a) is a schematic diagram of the repair; (b) is a photograph of gastric perforation repair in rats with different materials; (c) is H&E staining 15, 25 and 35 days after gastric perforation repair (scale bar: 200 µm), where the red arrow indicates the penetration wound, the yellow arrow indicates the suture wound, and the blue arrow indicates the healing contraction site; (d) is Masson staining 15, 25 and 35 days after gastric perforation repair (scale bar: 200 µm). DETAILED DESCRIPTION

[0057] In order to make the present invention easier to understand, specific embodiments of the present invention will be further described below.

[0058] The present invention is further described below in conjunction with embodiments and drawings, the purpose of which is to help better understand the content of the present invention, but these specific embodiments do not limit the protection scope of the present invention in any way.

[0059] Example 1 Preparation of the Thermosensitive Quaternary Ammonium Chitosan Derivative QCH The invention adopts the technology disclosed in the patent CN116948056A or CN116535540B previously applied by the applicant, adds 10 grams of chitosan to 490 grams of pre-frozen aqueous solution containing 11 wt% sodium hydroxide and 4 wt% urea, freezes at -20-30°C for 6-48 hours, takes out and mechanically stirs and thaws at room temperature, and repeats freezing and thawing to obtain a dissolved 2 wt% chitosan aqueous solution. Then, 2,3-epoxypropyltrimethylammonium chloride is added at a molar feed ratio of 1:1 to the chitosan unit, stirred fully at 2-5°C to dissolve it, and then stirred and reacted at 5°C for 24 hours, and the reaction solution is controlled to be a homogeneous transparent system. After that, the system is cooled to 2°C, and the pH value is adjusted to neutral with hydrochloric acid, washed by dialysis with pure water to remove urea and small salt molecules, and freeze-dried to obtain a sponge-like quaternary ammonium modified chitosan. According to the nuclear magnetic hydrogen spectrum 1HNMR, N appears at 3.15ppm. + The absorption peak of (CH3)3 indicates that the product has been quaternized and the degree of substitution of the reaction product is uniformly distributed. Its acetylation degree DA and quaternization degree of substitution DS were calculated by H NMR spectrum to be 0.92 and 0.07 respectively, with a yield of 88%, recorded as sample QCH1. Similarly, 2,3-epoxypropyltrimethylammonium chloride was added at a molar feed ratio of 2:1 to chitosan unit, and its acetylation degree DA and quaternization degree of substitution DS were calculated by H NMR spectrum to be 0.92 and 0.12 respectively, with a yield of 90%, recorded as sample QCH2. The aqueous solutions of both QCH1 and QCH2 were tested at a wavelength of 600 nanometers by rheological tests and UV-visible spectrophotometer, and they were temperature sensitive.

[0060] The quaternized modified chitosan prepared by using one or a mixture of any of epoxy short alkyl chain quaternary ammonium salts or chlorohydroxypropyl short alkyl quaternary ammonium salts such as 3-chloro-2-hydroxypropyltrimethylammonium chloride, 3-chloro-2-hydroxypropyltriethylammonium chloride, 2,3-epoxypropyltriethylammonium chloride, 2,3-epoxypropyltriethylammonium bromide, 2,3-epoxypropyltripropylammonium chloride to replace 2,3-epoxypropyltrimethylammonium chloride does not affect its temperature sensitivity.

[0061] Example 2 Preparation of QCH membrane toughened with glycerol (QCHF) The thermosensitive quaternized chitosan QCH2 prepared above was dissolved in 1.0 M NaOH solution at low temperature to prepare a 5wt% solution, and the completely dissolved QCH2 aqueous solution was centrifuged and degassed at low temperature (0-20°C). The degassed sample was coated on a glass plate (length and width 30cmx20 cm) with a coater (adjusting the thickness 0.5-1.0 mm), and placed in a 95% ethanol aqueous solution at room temperature (15-25°C) for crystallization and regeneration of a film. The completely regenerated film sample was then torn off the glass plate, and soaked in deionized water for 7 days to wash and remove residual ethanol and other small molecular residues to obtain a modified chitosan film. The modified chitosan film was then immersed in a 4 wt% glycerol aqueous solution for 12 hours, and then placed in air to dry to obtain a quaternized modified chitosan film QCHF (abbreviated as Q2F), which has few defects, good strength and transparency, and no chemical cross-linking agent is used in the whole process. The film material was cut into a dumbbell shape with a length of 50 mm, a gauge length of 20 mm, and a width of 4 mm, and stretched using a universal mechanical testing machine at a stretching speed of 2 mm / min. The tensile breaking strength was measured to be 87.8 ± 3.7 MPa, and the strain at this time was 38.9 ± 1.0%, which is higher than the tensile strength of all reported degradable dressings in existing technologies.

[0062] The effects of different regeneration temperatures, different glycerol immersion concentrations (0, 2, 4, 6, 9, 15 wt%), different drying methods, and different QCH substitution degrees on the membrane material were discussed; the mechanical properties of QCH2 films with different glycerol immersion concentrations are shown in Figure 2. Figure 2 As shown in Table 1, Figure 2 a in the middle is air dry, Figure 2b is freeze drying. It was found that the QCH film sample prepared at a low regeneration temperature (in 95% ethanol aqueous solution) such as -40 to 4°C had a white surface, poor light transmittance, and weak strength, while the QCH film prepared at a regeneration temperature of 10-30°C had good strength and transparency; it was found that the QCH film sample prepared without adding glycerol had poor toughness and was easy to break, while the strength and toughness of the sample with glycerol added were significantly improved, but the tensile fracture strength of the QCH film prepared by soaking in a high concentration of glycerol aqueous solution such as 15 wt% glycerol aqueous solution was significantly reduced, so the QCH film prepared by soaking in a glycerol aqueous solution with a concentration of 4-9% had good strength and transparency. QCHF membranes with high strength, high toughness, and high transparency can also be prepared by freeze drying or vacuum drying. Using thermosensitive quaternary ammonium chitosan QCH1 instead of thermosensitive quaternary ammonium chitosan QCH2 can also produce a QCH film with good strength and transparency. Its tensile strength at break is 23.3±3.1 MPa and its elongation at break is 26.3±0.7%. When the quaternary ammonium chitosan with too high a substitution degree (greater than or equal to 0.18) is used, the QCH film is weak and will break or dissolve when soaked in water. Therefore, a thermosensitive quaternary ammonium chitosan with a substitution degree of 0.07-0.17 and an acetylation degree of 0.88-0.94 is selected, and its weight average molecular weight is 5×10 4 ~5×10 6 The regeneration temperature is 10-30℃, and the QCH film toughened by immersion in a glycerol aqueous solution with a concentration of 4-9% has good strength and transparency.

[0063] Table 1 is the mechanical properties of QCH2 film

[0064] Example 3 Preparation of thermosensitive carboxymethyl chitosan derivatives and toughened CMCH membranes (CMCHF) thereof Using the technology disclosed in the applicant's prior patent CN116102769A or CN111378200A, a homogeneous method is used to prepare carboxymethyl chitosan with low deacetylation degree in a sodium hydroxide-urea system. Weigh 2 grams of purified chitosan and stir and disperse it in a 100-gram aqueous solution containing 11wt% sodium hydroxide and 4wt% urea in advance, freeze it at -20°C for 6 hours, take it out and mechanically stir and thaw it at room temperature, and repeat freezing and thawing twice to obtain a dissolved chitosan aqueous solution. Slowly add 11.4g of sodium chloroacetate to the chitosan solution, keep mechanical stirring so that the reactants can react evenly, react at 5°C for 12 hours, and then react at 15°C for 24 hours. Use 3M hydrochloric acid to adjust the pH value of the system to 7, and as the temperature rises, a white precipitate precipitates. The precipitate is separated, purified, and freeze-dried to obtain carboxymethyl chitosan (CMCH) with a yield of 87%. The 1H NMR spectrum showed that the acetylation degree of the product was 0.88 and the substitution degree was 0.12. The homogeneously synthesized CMCH solution was temperature sensitive and pH sensitive. It could dissolve under low temperature and alkaline conditions and undergo gelation under conditions of increased temperature and decreased alkalinity.

[0065] By changing the amount of sodium chloroacetate and controlling the molar ratio of sodium chloroacetate to sugar units in the chitin structure, a series of CMCH products with different degrees of substitution (0.07-0.20) can be obtained. By changing the ratio and reaction conditions, a series of carboxymethyl chitin with different degrees of substitution, low degree of deacetylation (0.72-0.92) can be obtained, and the molecular weight range is 5kDa~5000kDa. The above-mentioned thermosensitive CMCH (5 wt%) was dissolved in 1.0 M NaOH solution at 0℃. After centrifugal degassing, the CMCH solution was spread on a glass plate with a thickness of 1.0 mm, and then the glass plate was immersed in a 95% ethanol aqueous solution at -30℃ for 4 hours to regenerate CMCH. Subsequently, the regenerated CMCH film was peeled off the glass plate, immersed in deionized water for one week, and then dried at 50℃. By changing the regeneration temperature, from -30℃ to room temperature (10-30℃), a series of CMCH transparent films with good strength can be prepared. Then soak it in a 4 wt% glycerol aqueous solution for 12 hours, and then dry it in the air to obtain a thermosensitive carboxymethyl chitin toughened film CMCHF, which has few defects, good strength and transparency, and no chemical crosslinking agent is used in the whole process. When carboxymethyl chitin with too high a degree of substitution is used, the CMCH film obtained is weak and will crack or dissolve when soaked in water. Therefore, a thermosensitive carboxymethyl chitin with a degree of substitution of 0.07-0.20 is selected, the coagulation bath regeneration temperature is -30-30℃, and the CMCH film obtained by soaking and toughening with a glycerol aqueous solution with a concentration of 4-9% has good strength and transparency. Here, the thermosensitive modified chitin is dissolved in a 0.2-2.0 M NaOH solution and configured into a 3-8 wt% solution. The glass plate can also be replaced with other flat plates; the coagulation bath is any of 50%-100% methanol / water solution, 50%-100% ethanol / water solution or 50%-100% acetone / water solution, which does not affect the preparation of the toughened film.

[0066] Example 4 Preparation of composite tissue adhesive patch QCHFP First, dopamine-modified aldehyde-modified hyaluronic acid DAHA was synthesized: 2.0 g of sodium hyaluronate (weight average molecular weight of about 300,000) and 1.0 g of sodium periodate were dissolved in 200 mL of PBS buffer solution with a pH of 5.0, stirred for 5 h in the dark at room temperature (20-30°C), then 2 mL of ethylene glycol was added to the reaction solution, and the reaction was continued for 1 h, followed by dialyzing and freeze drying to obtain the aldehyde-modified hyaluronic acid (AHA) sample. 1.0 g of AHA was weighed and dissolved in 100 mL of PBS buffer solution with a pH of 5.0, 1.0 g of dopamine hydrochloride was added, stirred for 24 h at room temperature (20-30°C), and then dialyzed and freeze dried to obtain the dopamine-modified aldehyde-modified hyaluronic acid DAHA sample. The structures of AHA and DAHA were characterized by hydrogen nuclear magnetic resonance spectroscopy. The degree of oxidation of AHA was measured to be approximately 48.1% by hydroxylamine hydrochloride titration method. The degree of substitution of DAHA was calculated to be 29.3% by measuring the ultraviolet absorption of DAHA using the standard curve of dopamine hydrochloride concentration versus absorbance.

[0067] The present invention takes QCH2 as an example, and uses a glycerol-toughened thermosensitive quaternized chitin film QCHF prepared by immersing in a 4 wt% glycerol aqueous solution as a substrate (length and width 20 cmx10 cm), and immerses it in a solution containing 4 wt% glycerol and different concentrations of DAHA (2, 4, 5, 6, 10 wt%) for in-situ crosslinking for 24 h, and finally air-dried at room temperature to prepare a composite tissue adhesive patch, which is brown and transparent, has extremely high strength and toughness, and is referred to as QCHFP or Q2DF. First, the tensile strength of the composite tissue adhesive patch itself was tested, such as Figure 3 As shown, Q2DF-2 represents the composite tissue adhesive patch obtained by soaking in 2% DAHA solution, and Q2F represents the QCH film that was not soaked in DAHA solution and toughened by glycerol. It can be found that with the increase of DAHA concentration, the strength of QCHFP increased from 90.9 ± 0.8 MPa to 127.7 ± 1.5 MPa (these strengths are higher than the strength of QCHF without DAHA soaking (87.8 MPa). The highest tensile strength was obtained at a concentration of 10 wt%, and the tensile fracture strain also decreased from 25.5 ± 1.3% to 11.6 ± 0.5%, which was lower than the strain of QCHF without DAHA soaking (38.9 ± 1.0%). Figure 3 ). However, when the DAHA concentration is higher than 10%, the performance is uneven, the cross-linking degree may be too high, the film is too hard, and it is not suitable as an adhesive patch.

[0068] Example 5 Adhesion properties of composite tissue adhesive patch QCHFP In subsequent studies, QCH2 was selected as the substrate. The glycerol-toughened thermosensitive quaternized chitin membrane QCHF prepared by soaking in a 4 wt% glycerol aqueous solution was then soaked in a solution containing 4 wt% glycerol and 10 wt% DAHA for in-situ crosslinking for 24 h. Finally, the composite tissue adhesive patch QCHFP-10 was prepared by air drying at room temperature, which was used as the main research sample. Unless otherwise specified, it is abbreviated as QCHFP. In order to verify the rapid tissue adhesion properties of QCHFP, the present invention first treated the pig skin tissue with different liquid environments for 24 h to simulate the adhesion of normal tissue, blood, gastric juice and intestinal fluid environments. Subsequently, 0.1 mL of 0.4 M sodium periodate solution was used to wet the surface of the pig skin tissue, and then the QCHFP patch was quickly and lightly pressed, and adhesion was quickly achieved without falling off. The adhesion time was shorter than 30 seconds. The QCHFP patch was attached to fresh pig skin. The skin was first stretched, twisted, and bent repeatedly in the air. It was found that the patch would not fall off. At the same time, it was immersed in PBS (pH = 7.4) for 10 days. The above operations were also performed and it was found that the patch would not fall off ( Figure 4 b), indicating that the tissue patch has underwater adhesion stability. At the same time, the tissue patch was used to adhere to fresh rat heart, liver, kidney and stomach tissues without falling off, and it did not fall off even after being soaked in water for 10 days ( Figure 4 C), indicating that the tissue patch has good long-term wet tissue adhesion. The selection of different adhesion interfaces can be achieved by applying a low concentration of sodium periodate solution to the tissue interface that needs to be adhered. When the tissue interface on one side of the patch is adhered, the dopamine on the QCHFP patch on the opposite side will self-polymerize to form quinone, and the interface at this time will no longer have adhesion. If both sides of the patch need to be adhered, it is only necessary to apply an oxidant on the surface of the adhered tissue so that both sides of the QCHFP tissue patch can be adhered at the same time. Only the tissue surface moistened with an oxidant such as sodium periodate solution can be adhered by the QCHFP tissue patch, and the tissue surface not moistened with sodium periodate solution cannot be adhered by the QCHFP tissue patch, so it will not produce unwanted adhesion to other tissues. Because general adhesive materials inevitably lead to the formation of postoperative tissue adhesion and scar tissue due to their indiscriminate adhesion to surrounding tissues / organs and adhesion-induced inflammatory reactions. The tissue patch of the present invention can controllably adhere to the desired tissue, which has a wider range of clinical uses and can maintain long-term stability in air and water.

[0069] The adhesion strength of the composite tissue adhesive patch QCHFP was tested according to the lap shear measurement method of ASTM F2255-05 standard ( Figure 5 In (a), (b), it can be seen from the test results that no matter whether it is double-sided adhesion ( Figure 5 (a), (c), (d)) or one-sided adhesion ( Figure 5 In (b), (e), and (f), the adhesion strength increases with time, and the maximum adhesion strength of double-sided adhesion is 48.3 ± 0.6 kPa ( Figure 5 In (d), the single-sided adhesion still has strong adhesion at 96 h (175.4 ± 9.7 kPa, Figure 5 (f)), which is higher than the data of all products reported in the literature (Table 2). For example, the adhesion strength of commercial fibrin is less than 20 kPa, and single-sided adhesion has higher adhesion strength and efficiency. In summary, the QCHFP patch has the characteristics of rapid wet adhesion and long-term stability. The weight-average molecular weight of hyaluronic acid HA is selected in the range of 2×10 4 ~8×10 6 Similar results were obtained by replacing HA with a weight average molecular weight of about 300,000; aldehyded carboxymethyl chitosan was obtained by oxidizing carboxymethyl chitosan, and then the aldehyded carboxymethyl chitosan was reacted with dopamine hydrochloride through a Schiff base to obtain dopamine-grafted aldehyded carboxymethyl chitosan to replace the above-mentioned dopamine-modified aldehyded hyaluronic acid DAHA, which also obtained similar results; wherein the aldehyded rate of the polysaccharide polymer is 0.20-0.70, and the molar substitution degree of dopamine is 0.15-0.55, and similar results can be obtained, and the single-sided pig skin adhesion strength reaches more than 40kPa.

[0070] Table 2. Lap shear adhesion strength to pigskin in wet environment reported in the literature

[0071] [1] Xu Q, Hu E, Qiu H, Liu L, Li Q, Lu B, et al. Catechol-chitosan / carboxymethylated cotton-based Janus hemostatic patch for rapid hemostasis incoagulopathy. Carbohydr. Polym. 2023; 315: 120967 [2] Peng W, Liu C, Lai Y, Wang Y, Liu P, Shen J. An Adhesive / Anti-Adhesive Janus Tissue Patch for Efficient Closure of Bleeding Tissue withInhibited Postoperative Adhesion. Adv. Sci. 2023: 2301427. [3] Yang W, Kang X, Gao X, Zhuang Y, Fan C, Shen H, et al. BiomimeticNatural Biopolymer‐Based Wet‐Tissue Adhesive for Tough Adhesion, SeamlessSealed, Emergency / Nonpressing Hemostasis, and Promoted Wound Healing. Adv.Funct. Mater. 2023; 33(6): 2211340. [4] Wu J, Yuk H, Sarrafian TL, Guo CF, Griffiths LG, Nabzdyk CS, etal. An off-the-shelf bioadhesive patch for sutureless repair ofgastrointestinal defects. Science translational medicine. 2022; 14(630):eabh2857. [5] Deng J, Tang Y, Zhang Q, Wang C, Liao M, Ji P, et al. Abioinspired medical adhesive derived from skin secretion of Andriasdavidianus for wound healing. Adv. Funct. Mater. 2019; 29(31): 1809110. [6] Zhang K, Chen X, Xue Y, Lin J, Liang X, Zhang J, et al. Toughhydrogel bioadhesives for sutureless wound sealing, hemostasis andbiointerfaces. Adv. Funct. Mater. 2022; 32(15): 2111465. [7] Jung H, Kim MK, Lee JY, Choi SW, Kim J. Adhesive hydrogel patch with enhanced strength and adhesiveness to skin for transdermal drug delivery. Adv. Funct. Mater. 2020; 30(42): 2004407. [8] Fang Y, Zhang L, Chen Y, Wu S, Weng Y, Liu H. Polysaccharidesbased rapid self-crosslinking and wet tissue adhesive hemostatic powders for effective hemostasis. Carbohydr. Polym. 2023; 312: 120819. Example 6 Photothermal properties of composite tissue adhesive patch QCHFP In order to study the photothermal conversion capability of the QCHFP tissue patch, an 808 nm near-infrared laser system (Beijing Kaiplin) was used to irradiate the QCHFP tissue patch as an example, and the temperature change was monitored every 1 minute by a handheld infrared thermal imager (model: HM-TPH11-3AXF, Hikvision Micro-Image). Unless otherwise specified, the power density of the 808 nm laser was 2 W cm -2 The photothermal effect of the film patch was tested in a dry state and after being attached to pig skin in water for 10 days. Figure 6 As shown in (a), the photothermal efficiency increases significantly with the increase of DAHA concentration used to prepare QCHFP tissue patches. For example, for QCHFP tissue patches (Q2DF-10), the photothermal efficiency increases significantly with the increase of DAHA concentration used to prepare QCHFP tissue patches. -2 After 10 minutes of near-infrared light irradiation, the temperature of the QCHFP tissue patches increased by about 33°C from 22.3°C to 55.3°C, which showed a significant photothermal effect. However, the temperature of the QCHF tissue patches without DAHA was only increased by about 3-5°C after 10 minutes of near-infrared light irradiation, which was very small and the photothermal effect was very weak and not obvious. In addition, the temperature of these QCHFP tissue patches increased with the increase of laser power density, such as Figure 6 To verify its photothermal stability, the QCHFP tissue patch was irradiated with 808 nm laser at 2 W cm -2 After irradiation with the intensity of 10 min and then cooling to room temperature, there are still very similar photothermal effects after four laser on / off cycles, such as Figure 6As shown in (c), this indicates that the QCHFP tissue patch has good reusability and can be used for multiple cycles of photothermal therapy. It is green and environmentally friendly and can achieve the purpose of multiple photothermal treatments.

[0072] Since the QCHFP tissue patch has obvious absorption of light in the range of 500-900 nm, especially near-infrared light, it is converted into heat energy to produce a photothermal effect. For example, the absorption value of the QCHFP tissue patch at 660 nm is significantly higher than that at 808 nm. The warming effect is more obvious when using 660 nm laser irradiation. However, the near-infrared light of 660 nm has a greater impact on the surrounding skin and has weaker penetration. Therefore, near-infrared light of 808 nm is preferred.

[0073] Similarly, the present invention adheres the QCHFP patch to fresh pig skin and soaks it in saline for 10 days ( Figure 6 In (d), the material was irradiated with 808 nm laser of different powers and it was found that it not only had good photothermal effect and stability, but also had higher photothermal efficiency. This was mainly due to the effect of dopamine and self-aggregation to form polydopamine, which made the material adhered to the tissue have a higher photothermal effect.

[0074] Example 7 Photothermal antibacterial effect of composite tissue adhesive patch QCHFP The photothermal antibacterial properties of QCHFP tissue patch membrane were evaluated by agar plate counting method using Staphylococcus aureus (CMCC 26003) and Escherichia coli (ATCC 25922). The membrane material was made into a disc with a diameter of 8 mm using a puncher. For the positive control group, filter paper was cut into original pieces with a diameter of 8 mm, sterilized by ultraviolet for 12 h, and 200 μg / ml penicillin and streptomycin were prepared. Then the paper pieces were immersed in the corresponding antibiotic solution as a positive control, and the blank control was used without any material. The corresponding material was placed in each well of the 24-well plate, and 50 μL of Staphylococcus aureus or Escherichia coli suspension (10 7 CFU mL −1 ). 990 μL of nutrient broth (NB) medium was injected into each well. After incubation at 37 °C for 24 h, the bacterial suspension in the 24-well plate was transferred to a 48-well plate (10 μL per well), and then resuspended with 990 μL of culture medium. 100 μL of bacterial suspension was evenly spread on the agar plate (diluted 10 4 The culture medium was incubated at 37°C and 98% humidity for 24 h. Finally, a digital camera was used to observe and record the colonies of Staphylococcus aureus or Escherichia coli on the agar plate. Three samples were tested in each experimental group. The bactericidal ratio (BR) was calculated as follows: BR (%) = colony count in the experimental group / colony count in the blank control group × 100%.

[0075] The laser was used at 808 nm with a power of 2 W cm −2 All materials were irradiated with a power density of 1.50 nm for 5 minutes. In the absence of 808 nm near-infrared light irradiation, the relative survival rates of Escherichia coli and Staphylococcus aureus formed on the blank control group, Q2F and QCHFP patch samples were 100.0 ± 14.3, 72.8 ± 14.8, 47.7 ± 5.1% and 100.0 ± 6.9, 64.1 ± 7.1, 36.9 ± 3.7%, respectively. In contrast, the relative survival rates of Escherichia coli and Staphylococcus aureus in different groups after 5 minutes of near-infrared light irradiation were 100.0 ± 6.1, 64.5 ± 8.3, 0 and 100.0 ± 6.8, 57.0 ± 7.9, 0 ( Figure 7 (a)-(d)) show that there is no significant difference between the blank group and the Q2F group with or without near-infrared irradiation. The colony count of the QCHFP sample irradiated with near-infrared irradiation was significantly reduced, and the inhibition rate of Escherichia coli and Staphylococcus aureus reached 100%, which also shows that QCHFP has an effective photothermal antibacterial effect. For Q2F and QCHFP samples, they also showed a certain antibacterial ability without near-infrared irradiation, which is mainly due to the cationic positive charge of quaternized chitosan itself. QCHFP has a higher antibacterial ability than Q2F, which may be due to the antibacterial effect of a small amount of aldehyde groups on the surface of QCHFP. However, under the action of photothermal effect, the antibacterial ability of QCHFP samples is further improved. The inverted fluorescence microscope observed that the number of red dead bacteria increased significantly under the action of near-infrared irradiation of QCHFP. The scanning electron microscope SEM images showed that the number of Escherichia coli and Staphylococcus aureus decreased significantly under the action of near-infrared irradiation of QCHFP, and the rupture and deformation of bacterial structures were observed.

[0076] Example 8 In vitro and in vivo adhesion and occlusion properties of the composite tissue adhesive patch QCHFP Rat uterine leakage repair model: To explore the potential application of this new patch as a suture substitute in surgical operations, the rat uterine injury model was used to visually verify the effect of the tissue patch in preventing leakage. The untreated group was injected with blue dye at the bottom of the uterus, and the dye leaked from two incisions to confirm the presence of injury ( Figure 8 In the experimental group, one of the incisions was sealed with a QCHFP patch and blue dye was injected into the same position of the uterus immediately ( Figure 8In (b), the QCHFP patch sealed the repaired part without leakage, while the contralateral incision without the QCHFP patch had leakage, indicating that the QCHFP patch can effectively seal the damaged uterus. Similarly, the present invention uses the same method to evaluate the sealing performance of Q2F and commercial fibrin sealant (Fibrin sealant, porcine fibrin adhesive, Harbin Hanbang Medical Technology Co., Ltd.), and the commercial fibrin sealant also shows excellent sealing performance, but Q2F cannot seal the uterine gap. It shows that only the QCHFP tissue patch compounded with DAHA has good wet tissue sealing performance.

[0077] In addition, sealing the leakage of damaged tissue usually requires several days to several weeks to remain stable and effective. Referring to the ISO2759 fully automatic bursting strength tester, the present invention has built a bursting pressure test device, such as Figure 8 As shown in (c), a circular biopsy punch with a diameter of 4 mm was used to puncture fresh pig skin tissue, and then the perforation was sealed with QCHFP patch, fibrin sealant (porcine fibrin sealant, Harbin Hanbang Medical Technology Co., Ltd.) and tissue glue (3M, vetbond, Minnesota Mining Manufacturing Co., Ltd., USA) to test their sealing ability after the damaged pig skin was dried and soaked in PBS for 48 h. Figure 8 As shown in (d), the maximum sealing pressure of the QCHFP patch on the pig skin reached 92.33 ± 2.52 kPa, which is much higher than the human heart blood pressure of about 12 kPa, and also higher than commercial fibrin adhesive (4.48 ± 0.25 kPa) and tissue glue (89.09 ± 1.03 kPa). At the same time, in order to evaluate the long-term adhesion effect of the patch material under physiological wet environment, the present invention soaked the adhered pig skin in PBS aqueous solution for 48 hours and then re-measured its bursting pressure. At this time, the volume of the pig skin will expand and the wet adhesion of the pig skin will decrease, as shown in Figure 2. Figure 8 As shown in (e), the bursting pressures of the three materials are significantly reduced, but the bursting pressure of the QCHFP patch (3.0 ± 0.2 kPa) is also much stronger than that of tissue glue and fibrin adhesive (0.2 ± 0.0 and 0.4 ± 0.0 kPa). This is because the phenolic hydroxyl and aldehyde groups contained in the QCHFP patch react with the tissue, and its own high strength can seal the gap. Therefore, under the same extreme conditions, the QCHFP patch can show better sealing performance.

[0078] In the process of intestinal leakage repair and gastric tissue repair, the material is usually required to have a certain ability to resist acid and enzymatic hydrolysis. Therefore, the present invention established a liquid leakage model and quantitatively evaluated the ability of the QCHFP patch to resist liquid tissue leakage in vivo. The QCHFP patch was used to block holes with a diameter of 4 mm on the pig colon and pig skin. The damaged pig tissue was placed in a cup, and then 10 mL of PBS, simulated intestinal fluid (SIF) or simulated gastric fluid (SGF) was poured into the cup. Oscillate on an oscillator to simulate the dynamic process in the body, and test the possible leakage weight at different times. The results showed that ( Figure 8 In (f)-(h)), in PBS, both the QCHFP patch and the fibrin adhesive have good leak-proofing effects. In addition to covering the perforations, the leak-proof materials also cover a certain area of ​​tissue. The normal tissue without leak-proofing (blank group) also leaks, so the overall permeate weight is lower than that of the blank group. In the simulated intestinal fluid environment, the leak-proof results of the QCHFP patch are basically the same as those in PBS, indicating that the material itself and the adhesion are not affected by pancreatic enzymes, while the blank group and fibrin adhesive have a large amount of leakage at the 12th hour and the 8th hour, respectively, indicating that the fibrin adhesive is more sensitive to pancreatic enzymes. Similarly, in the simulated gastric fluid environment, since strong acid can corrode the large intestine tissue, the present invention chooses to use pig skin instead of the large intestine. It is worth noting that the fibrin adhesive basically leaks a lot within 2 hours, while the QCHFP patch is basically close to the blank group within 24 hours. It shows that the QCHFP patch has a certain ability to resist acid and enzymolysis. These results indicate that the QCHFP patch has robust tissue sealing properties in terms of sealing injury and leaky wound closure under both static and dynamic settings.

[0079] Example 9 Photothermal repair properties of the composite tissue adhesive patch QCHFP for skin wounds Establishment of rat full-thickness skin defect infection model ( Fig. 9 In (a), the photothermal healing performance of QCHFP patch as wound dressing was comprehensively evaluated, and the commercial wound dressing Renkang (medical burn dressing, Shaanxi Renkang Pharmaceutical Co., Ltd.) was used as a control. Fig. 9 As shown in (b) and (c), with the passage of time, the wound size of the entire experimental group gradually decreased. In the absence of near-infrared NIR808 nm laser irradiation, the wound healing efficiency of Q2F and QCHFP patches was higher than that of the blank group, indicating that the positive charge on the surface of quaternized chitosan can promote wound closure, while the commercial hydrogel dressing Renkang can provide a moist environment for the wound and promote granulation regeneration. Therefore, after the 14th day of treatment, the wound closure rate of Q2F, Renkang and QCHFP patches was higher. -2When the near-infrared laser was irradiated for 30 minutes every day, the healing effect of QCHFP patch was the best. The statistical analysis of the wound area during the healing process showed that the wound area of ​​Renkang, Q2F and QCHFP patch + NIR treatment groups were 2.8%, 2.0% and 0.9%, respectively ( Fig. 9 (b)), indicating that near-infrared has a positive therapeutic effect on wound healing.

[0080] In order to further explore the therapeutic effect of QCHFP patch in combination with near-infrared NIR 808 nm low-power illumination for 30 minutes per day on wound healing, the present invention performs H&E and Masson staining on the new skin tissue after treatment. After 14 days of treatment without NIR, each group had different degrees of epidermal regeneration, among which the epidermal tissue of the control group had not closed or grew unevenly. In addition, the thickness of the skin epithelium in the QCHFP patch group decreased, which was basically close to the tissue of normal skin, which is an important indicator of wound healing. The commercial dressings Renkang and Q2F were thicker than normal skin, indicating that thicker scar tissue was formed. In addition, a large number of skin attachments, including hair follicles, sebaceous glands, and regenerated blood vessels, were formed on the wound surface of the QCHFP patch group, which indicated effective regeneration of the skin, while only a small amount of skin attachments were found in Q2F, and basically no skin attachments were found in the blank group and commercial products. In the process of wound healing, collagen fibers play a vital role in structural repair and functional recovery. Densely packed bright blue collagen fibers were observed in the QCHFP group, and compared with the loosely packed collagen fibers in the other groups, the collagen deposition was more organized. QCHFP can also induce angiogenesis. After NIR treatment, it was found that the number of hair follicles, sebaceous glands and angiogenesis in the QCHFP group increased significantly, while no significant changes were observed in the other groups. In summary, QCHFP combined with near-infrared light therapy can promote skin regeneration and repair.

[0081] Example 10 Evaluation of the skin wireless suture repair effect of the composite tissue adhesive patch QCHFP The skin incision model of male Kunming mice (50 ± 5 g) was used to evaluate the adhesion persistence and wound healing performance of the QCHFP patch on the sutured wound in vivo. Four 1 cm long incisions were created in each Kunming mouse with a scalpel. The wound was first moistened with 50 μL of sodium periodate solution (0.4 M). Then, the QCHFP patch (1.5 cm long, 0.3 cm wide) was gently applied to the wound for 15 s to achieve adhesion. The ruptured wound site was reattached and fixed by the QCHFP patch, and initial closure was achieved ( Fig.10In (a), suture (8-0 non-absorbable suture), tissue glue (3M, vetbond, Minnesota Mining Manufacturing Co., Ltd., USA) and blank group (wound not treated) were used for experimental control to observe the recovery of skin incisions in each group. Since the active mice will cause the adhesive material to stretch, be scratched, or even be gnawed, this will put a great test on the stability of material adhesion and the irritation to the tissue. From the second day, the QCHFP patch was torn off, and it was observed that the QCHFP patch could adhere to the wound surface and had strong adhesion. Its wound recovery was better than conventional suture, and it scabbed the fastest. In the blank control group, the wound expanded due to the movement of the mice. In the tissue glue group, the wound expanded over a large area at the beginning due to the movement and gnawing of the mice, indicating that cyanoacrylate has a greater irritation to the mouse skin, and the adhesive interface lacks toughness and is easy to break ( Fig.10 (c)).

[0082] At 15 days, the wounds in the blank group and all experimental groups were basically healed, and the QCHFP patch treatment showed almost no scar formation, showing the best healing effect among all groups ( Fig.10 In the QCHFP patch group, no infection or inflammation was observed around the wound surface, and no wound closure or dehiscence was observed ( Fig.10 In addition, hair regeneration was observed through the incision, and no obvious scar formation was observed, indicating that the QCHFP patch promoted the overall healing of the wound. Its anti-inflammatory and antibacterial properties promoted repair, which gave it the advantages of skin suture and was faster than conventional sutures. Histological analysis was performed on the 15th day ( Fig.10 In (d), H&E staining results showed that epidermal regeneration was gradually completed and dermal glandular cavity regeneration was obvious. Fig.10 The results of (c) were consistent. The incision closure effect of the suture suture and QCHFP patch groups was better, the regenerated gland cavity and surrounding tissues were neatly arranged, and no obvious inflammatory cell infiltration was observed around the wound surface; while the upper skin of the blank group and Vetbond group was not completely closed, and there was still slight inflammatory cell infiltration and disordered tissue arrangement. The Masson staining results of the suture suture and QCHFP patch groups showed that the collagen accumulation in each group increased, the collagen accumulation in the blank group and Vetbond group was relatively loose, and the collagen accumulation in the QCHFP patch group was tightly and orderly arranged. All these indicate that the QCHFP patch can effectively suture wounds and promote repair.

[0083] Example 11 Hemostatic properties of the composite tissue adhesive patch QCHFP Test the in vitro whole blood coagulation index (BCI): Gently drop 20 μL of anticoagulated whole blood into 5 mg of sample, incubate at 37°C for 5 minutes, add 10 mL of deionized water to each tube, and then keep it in a shaker for 5 minutes (37°C, 60 rpm), aspirate the supernatant and measure the absorbance at 540 nm to calculate the coagulation index. The blank group without sample was tested as a control, and the calculation of BCI was based on the following formula: BCI (%) = As / Ab × 100% As and Ab represent the absorbance values ​​of the experimental group and the blank group, respectively. The results show that the BCI of QCHFP patch and Q2F are (27.4±0.7% and 38.4±1.1%), respectively. The former is very close to fibrin adhesive (26.5±2.5%), and the former is better than Avitene® (40%) (collagen powder, Davo Co., Ltd., a subsidiary of Bard), and both are much lower than the medical gauze that has been approved for marketing (91%).

[0084] Coagulation time measurement: 50 µL of liquid sample and 5 mg of solid sample were taken in a 96-well plate. The anticoagulant was mixed with calcium chloride (CaCl2, 0.1M) at a ratio of 10:1 (V:V), vortexed for 10 s, and 50 µL of blood sample was taken into the well. At the selected time point, each well was washed with PBS to completely remove the uncoagulated blood components. The time for a firm blood clot to form in each well was recorded as the coagulation time. Q2F and commercial collagen fiber powder Avitene® (collagen powder, Davo Co., Ltd., a subsidiary of Bard) had similar coagulation times (Ct), reaching 2.02±0.17 min, while the QCHFP patch had a shorter coagulation time (1.04±0.10 min), which was due to the introduction of dopamine and hyaluronic acid in the subsequent reaction to promote the coagulation properties of the composite material, and was also closer to the in vitro coagulation time of fibrin adhesive (0.89±0.23 min). The results of the platelet adhesion experiment showed that with the introduction of dopamine, the adhesion ability of platelets was enhanced, and the ammonium ions of dopamine and quaternary ammonium salts may activate platelets to be charged, causing platelet aggregation and accelerating the formation of platelet plugs. In short, the introduction of dopamine and hyaluronic acid in the QCHFP patch has the best in vitro procoagulant ability, and is close to or even exceeds the traditional commercial fibrin adhesive.

[0085] In vivo hemostatic effect of quaternary ammonium chitosan-modified composite tissue adhesive patch QCHFP The hemostatic effect of QCHFP adhesive patch was evaluated by using rat liver defect hemostasis model. SD rats (weight 250-300 g, female) were anesthetized and fixed on the surgical board. The abdominal hair was removed. The rat liver was surgically exposed. A pre-weighed filter paper was placed subcutaneously. A 1.5 mm incision was made in the liver with a scalpel. After 10 seconds of normal bleeding in the liver, the wound was briefly moistened with 0.4 M NaIO4 solution to accelerate sealing and hemostasis. Then, the QCHFP adhesive patch (15 x 15 mm 2 ) was attached to the wound, lightly pressed for 15 seconds to form adhesion, and the hemostasis time and blood loss were measured for 5 minutes. The experiment was repeated 5 times in each group. The hemostasis effects of the control group commercial gauze, HS-3 liquid dressing (Haisheng Health Technology (Qingdao) Co., Ltd.), QCHF, fibrin sealant (Fibrin sealant, porcine fibrin adhesive, Harbin Hanbang Medical Technology Co., Ltd.), and collagen sponge Avitene (Davoo Co., Ltd., a subsidiary of Bard) were evaluated in the same way, and the hemostasis time and blood loss of different materials were recorded.

[0086] from Fig.11 As can be seen from (a)-(d), the QCHFP adhesive patch exhibits the best hemostatic effect compared with commercial materials, e.g. Fig.11 (b) Blood stain photo. The blood loss of QCHFP adhesive patch and QCHF membrane were (17.5 ± 9.6 and 162.5 ± 17.1 mg) and the hemostasis time were (0.27 ± 0.04 and 1.31 ± 0.14 min) respectively. The hemostatic effect of QCHFP adhesive patch has surpassed the traditional excellent hemostatic material collagen fiber Avitene (Davoo Co., Ltd., a subsidiary of Bard). However, for such special-shaped wounds, it depends not only on the coagulation effect and morphology of the material, but also on the adhesion of the material itself. Therefore, fibrin sealant has better tissue adhesion, and its hemostatic effect (105.0 ± 20.8 mg and 0.64 ± 0.14 min) is better than that of QCHF membrane, but because the adhesion strength of gel-form fibrin sealant is weak, its effect is weaker than that of QCHFP adhesive patch.

[0087] Coagulation disorder is a great challenge in clinical rescue of patients with blood loss. In order to simulate the hemostatic effect of coagulation disorder, the tail-cut model of rats injected with an appropriate amount of heparin was first used to confirm that the coagulation time was significantly prolonged and the amount of bleeding was significantly increased after the injection of heparin. In the evaluation of heparinized rats, each experimental SD rat was intravenously injected with heparin sodium (50 UI / 100 g), and then waited for 10 minutes. The same operation as above was used to evaluate the hemostatic ability of the QCHFP adhesive patch on animals with coagulation disorder. Fig.11(e)-(h) The results showed that the blood loss and hemostasis time of the QCHFP adhesive patch (77.5 ± 17.1 mg and 0.83 ± 0.13min) were significantly lower than those of the other groups, especially the commercial fibrin sealant (725.0 ± 36.9 mg and 4.42 ± 0.09min). Although it is rich in thrombin and fibrin, for patients with coagulation disorders, the coagulation mechanism and the adaptability of the material itself to the wound are the most critical. From the comparison of the normal / heparinized hemostasis models, it can be seen that the fibrin sealant can easily block the bleeding site. The adhesion of the gel is one reason, and its own strength to withstand the impact of blood flow and blood pressure is also a reason. When the coagulation function of rats is disordered, a large amount of blood will break down the gel adhered to the wound, resulting in limited hemostasis effect. The QCHFP adhesive patch material itself carries a positive charge that can partially promote coagulation. Dopamine can promote adhesion to wound tissue, allowing the aggregated blood to form a blood clot in a relatively short period of time, inducing the recovery of the body's coagulation function. In addition, the material's own good strength can withstand the impact of blood flow and blood pressure without rupturing. Therefore, the QCHFP adhesive patch can show excellent hemostatic effect in coagulation disorder models.

[0088] Arterial injury can lead to massive bleeding, which is likely to be life-threatening if the bleeding is not stopped in time. The rat femoral artery transection hemostasis model was used for evaluation. The two ends of the rat femoral artery were clamped with a hemostatic clamp at a distance of about 1 cm, and then the artery was cut with surgical scissors. After wiping off the leaking blood, different materials were used to treat the cut wound to stop bleeding. After standing for 15 seconds, the hemostatic clamp was released, and the bleeding of the femoral artery was continuously monitored to evaluate the hemostatic effect. No external force was applied during the whole process. Due to the heavy bleeding of the femoral artery, materials without adhesion such as collagen sponge Avitene and QCHF membrane can be washed away by blood. However, even for liquid bandages HS-3 and fibrin sealants with adhesion effects, their own strength limitations resulted in unsatisfactory hemostatic effects. The QCHFP adhesive patch with tissue adhesion and good strength showed the best hemostatic effect (52.5± 25.0 mg and 0.51 ± 0.04min), with the least bleeding and shorter hemostasis time, and was better than the hemostatic effect of commercial comparison materials ( Fig.11 (i)-(l)).

[0089] Therefore, this QCHFP adhesive patch, which has rapid wet tissue adhesion and high strength, and has a cationic charge and synergistic effects of hyaluronic acid and dopamine, showed excellent hemostatic effects in liver defect hemostasis, even heparinized liver defect hemostasis, and femoral artery massive bleeding models.

[0090] Example 12 Gastrointestinal adhesion occlusion using the composite tissue adhesive patch QCHFP Rat gastric perforation repair model: Gastric perforation can cause a large amount of gastric fluid to flow into the abdominal cavity, causing chemical or bacterial peritonitis, which is seriously life-threatening. The SD rat model with severe gastric injury is used here to evaluate the effect of gastrointestinal adhesion occlusion. SD rats (300-350 g) were fasted for 12 hours before surgery to reduce the intestinal contents in the stomach, and the rats were anesthetized throughout the operation. To avoid abdominal contamination, the stomach was first separated by an abdominal incision with a scalpel, rinsed with PBS solution, and then wrapped with sterile surgical gauze. A 4 mm hole was opened on the side of the fundus of the stomach, and sterile gauze was used to stop bleeding immediately. The present invention uses a QCHFP patch (8 mm (L) × 8 mm (W)) to seal the perforation by gentle pressure for 30 s (i.e., 1 kPa), and it was found that it formed a firm adhesion seal with the gastric serosal tissue ( Fig.12 In (a), the rats were sealed with sutures (8-0 PLGA sutures, Jinhuan Enterprise Group, Shanghai) and fibrin sealant (Fibrin sealant, porcine fibrin sealant, Harbin Hanbang Medical Technology Co., Ltd.) as controls (n=4). The wounds closed with sutures took longer (5 minutes) to seal and had needle puncture tissue damage; when fibrin sealant was used to seal the perforation, a larger amount of protein glue was needed to seal the wound due to its fluidity, and it would also cause adhesion to other adjacent organs. Importantly, all rats sealed with fibrin sealant died before awakening from anesthesia, probably due to its greater toxicity. Overall, the QCHFP patch provided a simple, consistent, and completely conformable seal. During the 25-day observation period, the QCHFP patch maintained good bioadhesion, a new tissue layer had grown on the surface of the material, and the material itself was partially degraded, with no gastric fluid leakage, indicating successful sealing ( Fig.12 (b)). However, the surface of the gastric mucosa in the suture group had a clear hyperplastic layer, and the stomach in the suture group was slightly smaller than normal. It is speculated that the suture operation would affect the normal feeding of rats at this stage. After 35 days, the perforations in the QCHFP patch and suture groups were completely repaired.

[0091] The repaired gastric tissues were collected at designated time intervals, fixed with 4 vol% paraformaldehyde / PBS solution, and then embedded in paraffin for further histological and immunohistochemical analysis. The histological analysis was HE and Masson staining of the repaired rat gastric tissues. Immunohistochemical and immunofluorescent staining was CD68 (abcam, ab303565, 1:200) for evaluating the expression of macrophages. PCNA (boster, BM0104, 1:400) was used to evaluate positive proliferating cells, and the secondary antibody was HRP-labeled goat anti-mouse (Aspen, AS-1106, 1:200). CD31 (Affinity, AF6191, 1:200) was used to evaluate positive capillaries, α-SMA (boster, BM0002, 1:400) was used to evaluate positive arterioles, and secondary antibodies were CY3-labeled goat anti-rabbit (Aspen, AS-1109, 1:100), CoraLite488-labeled goat anti-rabbit (PTG, SA00013-2, 1:100), and CY3-labeled goat anti-mouse (Aspen, AS-1111, 1:100). At the same time, sections were incubated with hematoxylin for 5 minutes or DAPI for 10 minutes to stain the nuclei. Immunohistochemical staining and immunofluorescence images were observed using an upright microscope (Leica DM 2700M) and a confocal laser scanning microscope (CLSM, Lecia SP8), respectively. For further quantitative analysis, the percentage of expressed antibodies was analyzed from more than 100 data points using Image J. Further histological analysis by H&E and Masson staining showed that gastric perforation was repaired by fibrous tissue, mainly composed of collagen network and fibroblasts, while suture treatment of perforation resulted in denser fibrous tissue ( Fig.12 (c), (d)). It is worth mentioning that the QCHFP patch maintained a strong adhesion to the defect and surrounding tissues. After 15 days of sealing with the QCHFP patch, it was observed that the contours of the serosa and muscularis were clear, and the mucosal layer had been partially repaired, while the interstitial tissue in the suture group was loose and blurred, and the structure of the mucosal layer was disordered. In addition, after 25 days, the typical three-layer structure of the gastric wall around the perforation in the QCHFP patch group could be clearly observed ( Fig.12 In (c), (d), the mucosal layer of the suture group was not completely closed, and the local stress caused by the penetration of the suture caused severe deformation of the local tissue, and the entire stomach contracted ( Fig.12 The above results support the hypothesis of the present invention that the QCHFP patch is able to seal severe gastric perforation in an animal model without the assistance of additional staples or sutures.

[0092] The long-term therapeutic effect of the QCHFP patch on the sealed tissue was further evaluated by cellular immunology analysis. Although the perforation was found to be healing on the 15th day after the use of sutures, severe tissue inflammation was clearly observed in the defect area (serosa and muscular layer), indicating the presence of a large number of macrophages (CD68, 16.8%), which was in sharp contrast to the serosa and muscular layer test group using the QCHFP patch (8.1%). After 35 days of healing, the macrophages in the QCHFP patch group dropped to 0.4%, while the suture group still had about 2.7%. Excessive inflammation stimulates the overexpression of collagen and subsequent fibrosis, leading to scar formation. Masson staining also showed that the level of collagen fibers in the suture group was significantly higher than that in the QCHFP patch group.

[0093] Re-epithelialization and angiogenesis are key factors in the repair of gastric perforation. The present invention then further analyzed with PCNA staining (proliferation marker) and CD31 (endothelial cell marker). Immunohistochemical staining of PCNA, a proliferation marker in the G1 / S phase, showed that after 35 days of sealing the perforation with the QCHFP patch, the expression rate of proliferating cells was significantly reduced (from 59.7% to 9.9%), indicating that the wound was completely repaired to normal tissue, while the proliferating cells in the suture group still had a high expression rate (from 66.4% to 40.8%), indicating that it takes more time to completely repair the perforation. Similarly, after 35 days of closure, in the QCHFP patch immunofluorescence, the microvascular density of α-SMA (α-smooth muscle actin and mature blood vessels) and CD31 (neovascular endothelial cell marker) was significantly higher, 28% and 18% higher than the suture group, respectively. These immunohistochemical results show that the use of QCHFP patch as a gastric perforation seal can effectively accelerate the transition from the inflammatory phase to the repair and proliferation phase, inhibit excessive fibrosis, promote ECM remodeling, and provide nutrition for angiogenesis. In short, the ability of QCHFP patch to repair gastric perforation is significantly better than sutures and has good application prospects in clinical surgery.

[0094] Example 13 Composite tissue adhesive patch CMCHFP In Example 3, the thermosensitive carboxymethyl chitosan CMCH was used to prepare a toughened CMCH film. According to the method of Example 4, a transparent composite tissue adhesive patch CMCHFP with high strength and toughness can be prepared by using a dopamine-modified aldehyde-modified hyaluronic acid DAHA aqueous solution. The patch CMCHFP also has good tissue adhesion properties. At the same time, due to the dopamine layer on its surface, the patch CMCHFP also has a significant photothermal antibacterial repair effect, which can be used for wireless suture, hemostatic sealing and gastric perforation repair. However, if there is no light, the toughened CMCH film and patch CMCHFP made of thermosensitive carboxymethyl chitosan CMCH have basically no antibacterial properties because they are not positively charged.

[0095] Example 14 Biosafety of Composite Tissue Adhesive Patches QCHFP and CMCHFP Under the action of lysozyme, both Q2F and QCHFP patches can be degraded within 30 days. As the concentration of lysozyme increases, the degradation rate accelerates, and the degradation time of QCHFP is significantly longer than that of Q2F. This is because the cross-linking effect between dopamine-modified aldehyde hyaluronic acid DAHA and Q2F makes the structure of QCHFP more stable.

[0096] Hemolysis test: Hemolysis is an important indicator for evaluating the biocompatibility of biomaterials. When the polymer concentration reaches 3000μg / mL, the hemolysis rate of Q2F and QCHFP patches is less than 5%, indicating that these materials will not rupture red blood cells, showing blood compatibility, and are relatively safe materials in the field of biomedical materials. NIH 3T3 cells were incubated with extracts of Q2F and QCHFP patches of different concentrations (125 ~ 2000μg / mL) for 24 hours, and the cell viability values ​​were all higher than 80%. Almost no cell death (red staining) was observed by live / dead cell staining, indicating that these patch materials prepared by thermosensitive quaternary ammonium chitin have good biocompatibility. The composite tissue adhesive patch CMCHFP prepared by thermosensitive carboxymethyl chitin also has similar in vivo enzymatic degradability and good biocompatibility.

[0097] Comparative Example 1 A patch can be made by directly mixing a dopamine solution with a thermosensitive quaternary ammonium chitin or thermosensitive carboxymethyl chitin to make a film, but the adhesion is low and it cannot play the role of adhering to and sealing the tissue. Commercially available thermosensitive polyoxyethylene-polyoxypropylene-polyoxyethylene F127 (Sigma, item number P2443-250G) or polyester thermosensitive polymer PLGA-PEG-PLGA (Guangzhou Carbon Water Technology Co., Ltd., transition temperature 15±2°C, item number: 81000030, Lot NO. TS092917) was also tried to replace the thermosensitive quaternary ammonium chitin to make a film, but the strength was very weak. The patch prepared by using the dopamine-modified aldehyde-modified hyaluronic acid DAHA aqueous solution according to the method of Example 4 had very low adhesion and could not play the role of adhering to and sealing the tissue.

[0098] The specific implementation methods described above further illustrate the objectives, technical solutions and beneficial effects of the present invention in detail. It should be understood that the above description is only a specific example of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.

Claims

1. A method for preparing a multifunctional degradable tissue adhesive patch, characterized in that: The following steps are involved: preparing modified chitin membrane; The modified chitosan film is soaked in a toughening agent solution for toughening and modification, and the toughened and modified chitosan film is obtained after drying; The toughened modified chitosan film is immersed in a mixed solution containing a toughening agent and a degradable adhesive polymer to perform in-situ crosslinking, wherein the degradable adhesive polymer is a polysaccharide polymer containing both a dopamine group and an aldehyde group; The toughened modified chitosan film is then dried in an air environment to obtain a degradable tissue adhesive patch.

2. The method for preparing the degradable tissue adhesive patch according to claim 1, characterized in that: The toughening agent is a low molecular weight polyol, and the mass concentration of the polyol solution is 4-9 wt%.

3. The method for preparing the degradable tissue adhesive patch according to claim 1, characterized in that: The degradable adhesive polymer is dopamine hydroformylation hyaluronic acid or dopamine hydroformylation carboxymethyl chitosan.

4. The method for preparing the degradable tissue adhesive patch according to claim 1, characterized in that: The hydroformylation rate of the polysaccharide polymer is 0.20-0.70, and the molar substitution degree of dopamine is 0.15-0.

55.

5. The method for preparing the degradable tissue adhesive patch according to claim 1, characterized in that: The concentration of the toughening agent in the mixed solution matches the concentration of the toughening agent solution in the toughening modification, and the concentration of the degradable adhesive polymer in the mixed solution is 2-10 wt %.

6. The method for preparing the degradable tissue adhesive patch according to any one of claims 1 to 5, characterized in that: The method for preparing the modified chitin film is as follows: Dissolving the modified chitosan in an alkaline solution to prepare a modified chitosan solution; The modified chitosan solution is spread on a flat plate and adjusted to a desired thickness, and then the flat plate is immersed in a coagulation bath to regenerate a membrane; The obtained membrane is separated from the plate and then washed and purified to obtain a modified chitosan membrane.

7. The method for preparing the degradable tissue adhesive patch according to claim 6, characterized in that: The modified chitosan is a thermosensitive modified chitosan, and the acetylation degree of the thermosensitive modified chitosan is 0.72-0.94; its weight average molecular weight is 5×10 3 ~5×10 6 .

8. The method for preparing the degradable tissue adhesive patch according to claim 6, characterized in that: The coagulation bath is any one of a methanol aqueous solution, an ethanol aqueous solution or an acetone aqueous solution.

9. A degradable tissue adhesive patch, characterized in that: The product is prepared by the preparation method according to any one of claims 1 to 8.

10. Use of the degradable tissue adhesive patch according to claim 9 in the preparation of hemostatic products, products promoting wound tissue healing, tissue adhesive products, wound suture or photothermal antibacterial repair products.

Citation Information

Patent Citations

  • Carboxymethyl chitin porous granular material as well as preparation method and application thereof

    CN111378200A

  • Carboxymethyl chitin hemostatic sponge material as well as preparation method and application thereof

    CN116102769A

  • Preparation method and use of quaternary ammonium modified chitosan and its sponge and porous microspheres

    CN116535540B

  • Quaternized chitin, hemostatic sponge and preparation method of hemostatic sponge

    CN116948056A

Cited By

  • Self-adaptive super-contraction tendon adhesive with janus structure and preparation method of self-adaptive super-contraction tendon adhesive

    CN121534215A